Biden Administration Targets 10 Drugs for Medicare Price-Lowering Talks
The move is expected to cut costs for many patients, but it faces litigation from drugmakers and heavy criticism from Republican lawmakers. read more >
The move is expected to cut costs for many patients, but it faces litigation from drugmakers and heavy criticism from Republican lawmakers. read more >
Tough negotiations over reimbursement rates prompt another hospital to consider dropping UnitedHealthcare. read more >
Japanese drugmaker Eisai received conditional approval from the FDA in January based on early results suggesting Leqembi worked by clearing a sticky brain plaque linked to the disease. read more >
Authorities say Billy Joe Taylor of Lavaca used the money to fund a lavish lifestyle, purchasing luxury automobiles including a Rolls Royce. read more >
The drugmaker is seeking to halt the program, which was laid out in the Inflation Reduction Act and is expected to save taxpayers billions of dollars in the coming years. read more >
The two organizations said the relationship will "strengthen the ability of both provider to carry on their nonprofit missions in light of the evolving healthcare market and massice changes anticipated in how Medicare covers and pays for hospoce care over the next few years." read more >
In a news release, the company said it will open a center in Little Rock as part of a broader expansion that gives it a presence in 25 states. read more >
Instead, a majority — 58% — support the idea of increasing taxes on households making over $400,000 yearly to pay for Medicare. read more >
Patient revenue increased in 2022, even though patient volume hasn't quite returned to pre-pandemic levels. read more >
The drug maker plans to charge a list price of around $130 per dose for the vaccine in the U.S. read more >
One in five Medicare recipients currently uses medical marijuana. read more >
Biden wants to increase the Medicare tax rate from 3.8% to 5% on income exceeding $400,000 per year, including salaries and capital gains. read more >
As budget negotiations move ahead, expect the long history of GOP efforts to slash the popular entitlement programs for seniors to remain a politically powerful weapon the White House intends to wield. read more >
Newer and tougher penalties are meant to reduce improper charges on the taxpayers' tab for Medicare Advantage care. read more >
The analysis by the Arkansas Center for Health Improvement provides more evidence that health services in northwest Arkansas have been strained by recent demand. read more >
Overall, the company said Friday that its profit soared 17% to $4.76 billion in the final quarter of 2022. read more >
Staff at the Centers for Medicare and Medicaid Services are on the trail. They are secretly shopping for plans by calling the numbers linked to some online, TV and newspaper ads placed by these marketing firms, according to an agency memo sent to insurers last month. read more >
Despite the president's efforts, inflation is rising, and Republicans are capitalizing on higher prices, seeing openings in California and elsewhere to potentially pick up U.S. House seats. read more >
The bill mostly helps the roughly 49 million people who sign up for Medicare's drug coverage. But many will be left out from direct savings after lawmakers stripped cost-savings measures for a majority of those covered by private health insurance. read more >
Incentives for buying EVs, renewable energy production and domestic manufacturing look particularly good for Arkansas businesses. read more >
